TRINITY: Thought Regulation as a Transdiagnostic Process underlying Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and Obsessive Compulsive Disorder (OCD)
Summary
The purpose of this research study is to improve our understanding of conditions like Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and Obsessive Compulsive Disorder (OCD) in youth by focusing on their ability to regulate their thoughts and how this is linked to how they feel.
If you choose to volunteer in our study, you will attend one in-person session (up to 2.5 hours) to complete questionnaires, computer tasks, and possibly an interview assessing your diagnoses. For two weeks following the in-person session, you will also be asked to complete seven very short daily surveys (<1 minute each). The total time commitment is up to 4 hours spread over those two weeks. You will receive up to $105 as honorarium for your participation.
Eligibility
Eligible ages: 15 to 24
Accepts healthy participants: Yes
Inclusion criteria:
To participate, you must:
(1) be between the ages of 15 and 24 years;
(2) either have a diagnosis of Attention-Deficit/Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and/or Obsessive Compulsive Disorder (OCD), or are neurotypical (i.e., without any developmental conditions). If you are diagnosed with ADHD, ASD, and/or OCD, you can be taking medication for your condition but must not stop or change medications during the study. You can also show co-occurring diagnoses of these three conditions; and
(3) have access to a smartphone with network access and must be able to read, write, and understand English to complete daily surveys on your own.
Exclusion criteria:
Exclusion:
(1) diagnosis of fetal alcohol spectrum disorder, intellectual disability or a chronic neurologic condition (e.g. brain injury, epilepsy);
(2) not able to speak English fluently;
(3) no smartphone with network access; and
(3) a moderate or severe intellectual disability.
Participate
Fill out the following form if you want to participate in this research
UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is
committed to ensuring the privacy of all students, staff, and community members. Your personal information is being
collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used
and disclosed for the purposes outlined in UCalgary’s
Notice of
Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s
Privacy
Management Program.
Your personal information may be input into automated systems to generate content or make decisions,
recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection,
use, or disclosure of your personal information, please contact
accessandprivacy@ucalgary.ca.
Additional information
Contact information
If you are interested in participating, please email trinitystudy@ucalgary.ca or call 1-403-220-6722.
Principal investigator:
Julia Kam
Clinical trial:
No
REB-ID:
REB25-0785